MGO One Seven’s Immunogen Inc IMGN Stock Holding History

MGO One Seven’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,000	Closed	-$9K	–	1746
2018 Q4	$9K	Buy	+2,000	New	+$12.1K	﹤0.01%	1192
2018 Q1	$21K	Hold	2,000	–	–	0.01%	858
2017 Q4	$13K	Buy	+2,000	New	+$12.3K	0.01%	1008

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MGO One Seven's IMGN Position: Q1 2019 in Review

MGO One Seven sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 2,000 shares — an estimated $9K sold.

MGO One Seven first reported a position in IMGN in Q4 2017 and held it in 3 quarters. The position peaked at $21K in Q1 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

MGO One Seven reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 2,000 Immunogen Inc shares in Q1 2019, an estimated $9K.
MGO One Seven first reported a position in Immunogen Inc in Q4 2017 and held it in 3 quarters.
MGO One Seven's Immunogen Inc position peaked at $21K in Q1 2018.
212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.